Literature DB >> 25183195

Worth the weight: using inverse probability weighted Cox models in AIDS research.

Ashley L Buchanan1, Michael G Hudgens, Stephen R Cole, Bryan Lau, Adaora A Adimora.   

Abstract

In an observational study with a time-to-event outcome, the standard analytical approach is the Cox proportional hazards regression model. As an alternative to the standard Cox model, in this article we present a method that uses inverse probability (IP) weights to estimate the effect of a baseline exposure on a time-to-event outcome. IP weighting can be used to adjust for multiple measured confounders of a baseline exposure in order to estimate marginal effects, which compare the distribution of outcomes when the entire population is exposed versus when the entire population is unexposed. For example, IP-weighted Cox models allow for estimation of the marginal hazard ratio and marginal survival curves. IP weights can also be employed to adjust for selection bias due to loss to follow-up. This approach is illustrated using an example that estimates the effect of injection drug use on time until AIDS or death among HIV-infected women.

Entities:  

Mesh:

Year:  2014        PMID: 25183195      PMCID: PMC4250953          DOI: 10.1089/AID.2014.0037

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  32 in total

1.  Fallibility in estimating direct effects.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Int J Epidemiol       Date:  2002-02       Impact factor: 7.196

2.  Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.

Authors:  J M Robins; D M Finkelstein
Journal:  Biometrics       Date:  2000-09       Impact factor: 2.571

3.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

Authors:  M A Hernán; B Brumback; J M Robins
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

4.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

5.  Marginal structural models as a tool for standardization.

Authors:  Tosiya Sato; Yutaka Matsuyama
Journal:  Epidemiology       Date:  2003-11       Impact factor: 4.822

6.  Adjusted survival curves with inverse probability weights.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Comput Methods Programs Biomed       Date:  2004-07       Impact factor: 5.428

7.  Marginal structural models for the estimation of direct and indirect effects.

Authors:  Tyler J VanderWeele
Journal:  Epidemiology       Date:  2009-01       Impact factor: 4.822

8.  Randomized trials analyzed as observational studies.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; James M Robins
Journal:  Ann Intern Med       Date:  2013-10-15       Impact factor: 25.391

9.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

10.  Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán; James M Robins; Kathryn Anastos; Joan Chmiel; Roger Detels; Carolyn Ervin; Joseph Feldman; Ruth Greenblatt; Lawrence Kingsley; Shenghan Lai; Mary Young; Mardge Cohen; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2003-10-01       Impact factor: 4.897

View more
  31 in total

1.  Short-term outcomes for lung cancer resection surgery in HIV infection.

Authors:  Keith M Sigel; Kimberly Stone; Juan P Wisnivesky; Lesley S Park; Chung Yin Kong; Michael J Silverberg; Sheldon Brown; Matthew Goetz; Maria C Rodriguez-Barradas; Cynthia Gibert; Fatma Shebl; Roger Bedimo; Roxanne Wadia; Joseph King; Kristina Crothers
Journal:  AIDS       Date:  2019-07-01       Impact factor: 4.177

2.  Longitudinal Associations of US Acculturation With Cognitive Performance, Cognitive Impairment, and Dementia.

Authors:  Erline E Martinez-Miller; Whitney R Robinson; Christy L Avery; Yang C Yang; Mary N Haan; Aric A Prather; Allison E Aiello
Journal:  Am J Epidemiol       Date:  2020-11-02       Impact factor: 4.897

3.  Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation.

Authors:  Jennifer S Lee; Stephen R Cole; David B Richardson; Dirk P Dittmer; William C Miller; Richard D Moore; Mari Kitahata; Christopher Mathews; Kenneth Mayer; Elvin Geng; Chad J Achenbach; Joseph J Eron
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

4.  Lost Opportunities Concerning Loss-to-Follow-up: A Response to Elul et al.

Authors:  Paula D Strassle; Jacqueline E Rudolph; Bryna J Harrington; Sara N Levintow
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

5.  Association of History of Injection Drug Use with External Cause-Related Mortality Among Persons Linked to HIV Care in an Urban Clinic, 2001-2015.

Authors:  Kanal Singh; Geetanjali Chander; Bryan Lau; Jessie K Edwards; Richard D Moore; Catherine R Lesko
Journal:  AIDS Behav       Date:  2019-12

6.  Self-reported myocardial infarction and fatal coronary heart disease among oil spill workers and community members 5 years after Deepwater Horizon.

Authors:  Jean Strelitz; Alexander P Keil; David B Richardson; Gerardo Heiss; Marilie D Gammon; Richard K Kwok; Dale P Sandler; Lawrence S Engel
Journal:  Environ Res       Date:  2018-09-22       Impact factor: 6.498

7.  Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.

Authors:  Amit G Singal; Nicole E Rich; Neil Mehta; Andrea D Branch; Anjana Pillai; Maarouf Hoteit; Michael Volk; Mobolaji Odewole; Steven Scaglione; Jennifer Guy; Adnan Said; Jordan J Feld; Binu V John; Catherine Frenette; Parvez Mantry; Amol S Rangnekar; Omobonike Oloruntoba; Michael Leise; Janice H Jou; Kalyan Ram Bhamidimarri; Laura Kulik; George N Ioannou; Annsa Huang; Tram Tran; Hrishikesh Samant; Renumathy Dhanasekaran; Andres Duarte-Rojo; Reena Salgia; Sheila Eswaran; Prasun Jalal; Avegail Flores; Sanjaya K Satapathy; Sofia Kagan; Purva Gopal; Robert Wong; Neehar D Parikh; Caitlin C Murphy
Journal:  Gastroenterology       Date:  2019-07-30       Impact factor: 22.682

8.  When to Censor?

Authors:  Catherine R Lesko; Jessie K Edwards; Stephen R Cole; Richard D Moore; Bryan Lau
Journal:  Am J Epidemiol       Date:  2018-03-01       Impact factor: 4.897

9.  Generalizing the per-protocol treatment effect: The case of ACTG A5095.

Authors:  Haidong Lu; Stephen R Cole; H Irene Hall; Enrique F Schisterman; Tiffany L Breger; Jessie K Edwards; Daniel Westreich
Journal:  Clin Trials       Date:  2018-10-17       Impact factor: 2.486

10.  Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy.

Authors:  Sarah J Willis; Stephen R Cole; Daniel Westreich; Andrew Edmonds; Christopher B Hurt; Svenja Albrecht; Kathryn Anastos; Michael Augenbraun; Margaret Fischl; Audrey L French; Aley G Kalapila; Roksana Karim; Marion G Peters; Michael Plankey; Eric C Seaberg; Phyllis C Tien; Adaora A Adimora
Journal:  AIDS       Date:  2018-03-13       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.